These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34672194)

  • 21. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.
    Dai Y; Cao Y; Zhang Z; Vallurupalli S; Mehta JL
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):19-27. PubMed ID: 28084571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.
    Hu Q; Zhou M; Zhu H; Lu G; Zheng D; Li H; Hao K
    Biomed Pharmacother; 2017 Feb; 86():88-94. PubMed ID: 27951420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail.
    Wu H; Wang Y; Huang J; Li Y; Lin Z; Zhang B
    Biomed Pharmacother; 2023 Feb; 158():114175. PubMed ID: 36587556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eupatilin inhibits xanthine oxidase in vitro and attenuates hyperuricemia and renal injury in vivo.
    Xu G; Wu L; Yang H; Liu T; Tong Y; Wan J; Han B; Zhou L; Hu X
    Food Chem Toxicol; 2024 Jan; 183():114307. PubMed ID: 38052408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice.
    Xu L; Lin G; Yu Q; Li Q; Mai L; Cheng J; Xie J; Liu Y; Su Z; Li Y
    Front Pharmacol; 2021; 12():645879. PubMed ID: 33959014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity.
    Hou CW; Lee YC; Hung HF; Fu HW; Jeng KC
    Am J Chin Med; 2012; 40(5):979-91. PubMed ID: 22928829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Basis for Use of a Novel Compound in Hyperuricemia: Anti-Hyperuricemic and Anti-Inflammatory Effects.
    Zhao L; Li Y; Yao D; Sun R; Liu S; Chen X; Lin C; Huang J; Wang J; Li G
    Front Pharmacol; 2021; 12():772504. PubMed ID: 34819865
    [No Abstract]   [Full Text] [Related]  

  • 28. Lonicera hypoglauca inhibits xanthine oxidase and reduces serum uric acid in mice.
    Chien SC; Yang CW; Tseng YH; Tsay HS; Kuo YH; Wang SY
    Planta Med; 2009 Mar; 75(4):302-6. PubMed ID: 19184967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid-lowering effect of harpagoside and its protective effect against hyperuricemia-induced renal injury in mice.
    Fu Q; Zhang JJ; Zhu QF; Yu LL; Wang F; Li J; He X; Ao JL; Xu GB; Wei MC; Liao XJ; Liao SG
    Biochem Biophys Res Commun; 2024 Jul; 716():150038. PubMed ID: 38704891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DKB114, A Mixture of
    Lee YS; Kim SH; Yuk HJ; Kim DS
    Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
    [No Abstract]   [Full Text] [Related]  

  • 31. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats.
    Tang B; Chen GX; Liang MY; Yao JP; Wu ZK
    Int J Cardiol; 2015 Feb; 180():134-41. PubMed ID: 25438234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of
    Xu Y; Cao X; Zhao H; Yang E; Wang Y; Cheng N; Cao W
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444825
    [No Abstract]   [Full Text] [Related]  

  • 33. Curcumin ameliorates monosodium urate-induced gouty arthritis through Nod-like receptor 3 inflammasome mediation via inhibiting nuclear factor-kappa B signaling.
    Li X; Xu DQ; Sun DY; Zhang T; He X; Xiao DM
    J Cell Biochem; 2019 Apr; 120(4):6718-6728. PubMed ID: 30592318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active components from Lagotis brachystachya maintain uric acid homeostasis by inhibiting renal TLR4-NLRP3 signaling in hyperuricemic mice.
    Zhu JX; Yang HY; Hu WQ; Cheng J; Liu Y; Yi LT; Cheng HY
    Inflammopharmacology; 2021 Aug; 29(4):1187-1200. PubMed ID: 34244900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
    Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
    J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ellagic Acid Protects Dopamine Neurons via Inhibition of NLRP3 Inflammasome Activation in Microglia.
    He XM; Zhou YZ; Sheng S; Li JJ; Wang GQ; Zhang F
    Oxid Med Cell Longev; 2020; 2020():2963540. PubMed ID: 33294118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study.
    Alghamdi YS; Soliman MM; Nassan MA
    BMC Pharmacol Toxicol; 2020 Feb; 21(1):10. PubMed ID: 32041665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice.
    Wang MX; Liu YL; Yang Y; Zhang DM; Kong LD
    Eur J Pharmacol; 2015 Jan; 747():59-70. PubMed ID: 25499818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice.
    Yang Y; Zhang DM; Liu JH; Hu LS; Xue QC; Ding XQ; Kong LD
    J Ethnopharmacol; 2015 Jul; 169():49-59. PubMed ID: 25914040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis.
    Lemos Lima Rde C; Ferrari FC; de Souza MR; de Sá Pereira BM; de Paula CA; Saúde-Guimarães DA
    J Ethnopharmacol; 2015 Feb; 161():194-9. PubMed ID: 25500302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.